Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foster (beclomethasone + formoterol) versus formoterol in severe COPD
2009-012546-23Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclometasone dipropionate + formoterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: Superiority of CHF 1535 versus formoterol and Pulmonary function endpoints. Started Jul 2009; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-012546-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012546-23.